Clinical Trials
7 trialsNCT02961257 2022-05-12
CABASTY
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 3 Completed
NCT02319135 2020-04-06
FLUGAZA
PETHEMA Foundation
Phase 3 Completed
NCT00615602 2015-03-04
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Hellenic Oncology Research Group
Phase 3 Completed
NCT01985724 2014-05-14
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Hellenic Oncology Research Group
Phase 3 Completed
NCT00499018 2011-02-15
DLCL04
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
NCT00932217 2009-07-03
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
University of Pisa
Phase 3 Unknown
NCT00431080 2008-01-21
Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Hellenic Oncology Research Group
Phase 3 Completed